Hydroxychloroquine Versus Pioglitazone in Combination Treatment for Type 2 Diabetes Mellitus
Clinical trial NCT02303405 · TERMINATED
Trial details
- NCT number
- NCT02303405
- Sponsor
- Charles Drew University of Medicine and Science
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2017-11-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.